March 4, 2026
Headlines

Phathom Pharmaceuticals Stock Doubles After FDA Grants Full 10-Year Exclusivity For Voquezna

Sumain Faisal01 mins

Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) shares are trading lower Friday after the company announced a major regulatory win.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News